FDA issued a Warning Letter to Inopak Ltd on 2/21/2019 for a later inspection.
483 Inopak Feb 2015

483 Inopak Feb 2015

Jose Cayuela FDA$119.00 - Available Now

FDA investigators audited the Inopak - Ringwood, NJ, United States facility and issued 5 inspectional observations (via FDA 483) on 11 Feb 2015.

Product details

  • Category: Human Drugs
  • Number of Observations: 5
  • Inspection end: 11 Feb 2015
  • Location: Ringwood, United States
  • FEI: 1000122232
Add To Cart